Monday, June 13, 2016

BRIEF-Shire receives FDA breakthrough therapy designation

* Granted breakthrough therapy designation for two

investigational products for rare diseases: SHP621 and SHP625

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)